1,216 results on '"Nelson, Harold S"'
Search Results
52. Injection Immunotherapy for Inhalant Allergens
53. Contributors
54. Allergen-Specific Immunotherapy
55. 85 - Injection Immunotherapy for Inhalant Allergens
56. An evidence-based analysis of house dust mite allergen immunotherapy: A call for more rigorous clinical studies
57. Introducing atopy
58. Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial
59. Allergen immunotherapy: Where is it now?
60. Advances in upper airway diseases and allergen immunotherapy
61. Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
62. Combination therapy of long-acting β agonists and inhaled corticosteroids in the management of chronic asthma
63. 2020 Updated Asthma Guidelines: Allergen immunotherapy
64. Are meta-analysis–based comparisons solid evidence?
65. Is Sublingual Immunotherapy Ready for Use in the United States?
66. Long-Term Safety of Flunisolide Hydrofluoroalkane Metered-Dose Inhaler in Adults and Adolescents with Asthma
67. Evaluation of a skin test device designed to be less painful
68. List of Contributors
69. In Vivo Testing for Immunoglobulin E-Mediated Sensitivity
70. Skin testing: a survey of allergists
71. Efficacy and safety of allergen immunotherapy in children
72. Skin testing
73. Long-Acting Beta-Agonists in Adult Asthma: Evidence that these Drugs are Safe
74. Immunologic response to administration of standardized dog allergen extract at differing doses
75. Sublingual immunotherapy: A comprehensive review
76. Advances in upper airway diseases and allergen immunotherapy
77. Immunotherapy for Inhalant Allergens
78. Contributors
79. Sublingual immunotherapy: Allergen specific or placebo effect?
80. Allergy immunotherapy: Future directions for the 2020s
81. Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy
82. Allergy immunotherapy for inhalant allergens: Strategies to minimize adverse reactions
83. β2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate
84. Meeting the Obligation to Balance Bioethics and Clinical Trial Design in Asthma
85. Fluticasone Propionate Nasal Spray Is Superior to Montelukast for Allergic Rhinitis While Neither Affects Overall Asthma Control
86. Recommendations for appropriate sublingual immunotherapy clinical trials
87. News Beyond Our Pages
88. Multiallergen immunotherapy for allergic rhinitis and asthma
89. Jack Pepysʼ contributions to the medical literature
90. Update on the safety of long-acting β-agonists in combination with inhaled corticosteroids for the treatment of asthma
91. Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma: A Randomized, Controlled Trial
92. News Beyond Our Pages
93. The Editorsʼ Choice
94. Safety of Long-Acting β-Agonists
95. The Editorsʼ Choice
96. Why SMART About Second-Line Treatment When First-Line Treatment Is Being Ignored?
97. Comments on the Salmeterol Multicenter Asthma Research Trial
98. Cause of Death in the SMART Trial
99. The Salmeterol Multicenter Asthma Research Trial
100. Effects of Esomeprazole 40 mg Twice Daily on Asthma: A Randomized Placebo-controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.